Roles of microRNAs in chronic pediatric diseases and their use as potential biomarkers: A review

Arch Biochem Biophys. 2021 Mar 15:699:108763. doi: 10.1016/j.abb.2021.108763. Epub 2021 Jan 16.

Abstract

MicroRNAs (miRNAs) are small non-coding highly conserved RNA molecules that can act as master regulators of gene expression in a sequence-specific manner either by translation repression or mRNA degradation, influencing a wide range of biologic processes that are essential for the maintenance of cellular homeostasis. Chronic pediatric diseases are the leading cause of death worldwide among children and the recent evidence indicates that aberrant miRNA expression significantly contributes to the development of chronic pediatric diseases. This review focuses on the role of miRNAs in five major chronic pediatric diseases including bronchial asthma, congenital heart diseases, cystic fibrosis, type 1 diabetes mellitus, and epilepsy, and their potential use as novel biomarkers for the diagnosis and prognosis of these disorders.

Keywords: Bronchial asthma; Congenital heart disease; Cystic fibrosis; Epilepsy; Type 1 diabetes mellitus; microRNA biomarker.

Publication types

  • Review

MeSH terms

  • Asthma / diagnosis
  • Asthma / metabolism
  • Asthma / physiopathology*
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Chronic Disease
  • Cystic Fibrosis / diagnosis
  • Cystic Fibrosis / metabolism
  • Cystic Fibrosis / physiopathology*
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Epilepsy / diagnosis
  • Epilepsy / metabolism
  • Epilepsy / physiopathology*
  • Heart Defects, Congenital / diagnosis
  • Heart Defects, Congenital / metabolism
  • Heart Defects, Congenital / physiopathology*
  • Humans
  • MicroRNAs / blood
  • MicroRNAs / metabolism
  • MicroRNAs / physiology*
  • Pediatrics
  • Prognosis

Substances

  • Biomarkers
  • MicroRNAs